SPB:NYSESpectrum Brands Holdings, Inc. Analysis
Data as of 2026-06-06 - not real-time
$81.55
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Q2 2026 earnings beat expectations with adjusted EPS of $1.25 versus the $1.07 consensus and revenue growth of 4.9%, driven by strong pet‑care and home‑and‑garden sales. The stock is trading at $81.55, comfortably above its 20‑day ($78.51) and 50‑day ($79.38) SMAs, while the MACD remains bullish and the RSI sits at a neutral 56, suggesting limited short‑term downside despite a recent dip in trading volume.
Valuation appears attractive: a discounted cash‑flow model places fair value near $130, and analyst consensus targets average $85, implying a modest upside of roughly 7% from current levels. The dividend yield of 2.31% (payout ~37%) is supported by solid operating cash flow ($330M) and free cash flow ($222M), while the company’s low beta (0.75) and defensive consumer‑staples positioning temper the high 30‑day volatility (≈43%).
Valuation appears attractive: a discounted cash‑flow model places fair value near $130, and analyst consensus targets average $85, implying a modest upside of roughly 7% from current levels. The dividend yield of 2.31% (payout ~37%) is supported by solid operating cash flow ($330M) and free cash flow ($222M), while the company’s low beta (0.75) and defensive consumer‑staples positioning temper the high 30‑day volatility (≈43%).
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat and revenue momentum
- Bullish MACD with price above short‑term averages
- Proximity to near‑term resistance around $83
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to DCF fair value and analyst targets
- Stable dividend yield with sustainable payout
- Defensive consumer‑staples sector offering earnings resilience
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term upside potential from intrinsic valuation
- Consistent cash‑flow generation supporting dividend growth
- Low beta and defensive positioning limiting market‑wide volatility
Key Metrics & Analysis
Financial Health
Revenue Growth4.90%
Profit Margin4.47%
P/E Ratio15.9
ROE6.64%
ROA2.87%
Debt/Equity38.17
P/B Ratio1.0
Op. Cash Flow$330.5M
Free Cash Flow$222.4M
Technical Analysis
TrendNeutral
RSI56.5
Support$71.63
Resistance$82.97
MA 20$78.51
MA 50$79.38
MA 200$65.98
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Fair Value$130.30
Target Price$87.43
Upside/Downside7.21%
GradeUndervalued
TypeValue
Dividend Yield2.31%
Risk Assessment
Beta0.75
Volatility42.90%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.